- Home
- IRIX vs CLDI Comparison
IRIX vs CLDI Comparison
Compare IRIX & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRIX
- CLDI
- Stock Information
- Founded
- IRIX 1989
- CLDI 2014
- Country
- IRIX United States
- CLDI United States
- Employees
- IRIX N/A
- CLDI N/A
- Industry
- IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IRIX Health Care
- CLDI Health Care
- Exchange
- IRIX Nasdaq
- CLDI Nasdaq
- Market Cap
- IRIX 20.6M
- CLDI 22.3M
- IPO Year
- IRIX 1996
- CLDI N/A
- Fundamental
- Price
- IRIX $1.03
- CLDI $0.58
- Analyst Decision
- IRIX Hold
- CLDI Strong Buy
- Analyst Count
- IRIX 1
- CLDI 2
- Target Price
- IRIX $2.00
- CLDI $15.00
- AVG Volume (30 Days)
- IRIX 142.5K
- CLDI 366.6K
- Earning Date
- IRIX 03-27-2025
- CLDI 05-13-2025
- Dividend Yield
- IRIX N/A
- CLDI N/A
- EPS Growth
- IRIX N/A
- CLDI N/A
- EPS
- IRIX N/A
- CLDI N/A
- Revenue
- IRIX $48,669,000.00
- CLDI N/A
- Revenue This Year
- IRIX N/A
- CLDI N/A
- Revenue Next Year
- IRIX $5.44
- CLDI N/A
- P/E Ratio
- IRIX N/A
- CLDI N/A
- Revenue Growth
- IRIX N/A
- CLDI N/A
- 52 Week Low
- IRIX $0.78
- CLDI $0.53
- 52 Week High
- IRIX $3.65
- CLDI $8.30
- Technical
- Relative Strength Index (RSI)
- IRIX 45.12
- CLDI 33.04
- Support Level
- IRIX $0.78
- CLDI $0.53
- Resistance Level
- IRIX $1.07
- CLDI $0.79
- Average True Range (ATR)
- IRIX 0.12
- CLDI 0.06
- MACD
- IRIX 0.02
- CLDI -0.01
- Stochastic Oscillator
- IRIX 54.35
- CLDI 14.57
About IRIX IRIDEX Corporation
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.